Equity Investment Analyst (Pharma & Biotech)
6 - 10 years
Atlanta, GA
Full-time
Onsite
1 month ago
About the role
Korn Ferry has partnered with our client on their search for the role, Equity Investment Analyst (Pharma & Biotech).
Education:
A Bachelor’s degree is required while a CFA designation or MBA are strongly preferred. Advanced scientific training (PhD, MD) is a plus.
Qualifications:
Responsibilities:
SE#510791481
Education:
A Bachelor’s degree is required while a CFA designation or MBA are strongly preferred. Advanced scientific training (PhD, MD) is a plus.
Qualifications:
- Experience as an equity analyst for at least 8 or more years, specialized in pharmaceutical, biotechnology, and/or managed care sectors.
- Demonstrated investment track record based on rigorous fundamental analysis.
- Deep understanding of financial markets, equity valuation, and long-term investing.
- Self-motivated and able to operate independently within a collegial, team-based environment.
- Independent analytical thinker with the ability to cover a broad universe of public equities.
- Experience in pure independent valuation and analysis, without reliance on management access, sell-side research, or portfolio manager direction.
- Clearly articulated analytical framework and a well-developed, repeatable investment process.
- Experience presenting, defending, and validating investment recommendations to senior investors.
- High comfort level in a performance-based investment environment.
Responsibilities:
- Report directly to the Co-Directors of Research.
- Contribute to internal equity investment funds across both Domestic and International portfolios.
- Provide primary coverage of pharmaceutical, biotechnology, and managed care equities as part of a ~20 analyst research team.
- Perform fundamental research across a broad universe of domestic and international stocks spanning market capitalizations.
- Independently assess companies using SEC filings, industry data, and other primary research sources.
- Analyze income statements, balance sheets, cash flow statements, competitive positioning, industry structure, and qualitative risk factors.
- Develop sector allocation and deployment strategies within specific GICS industry groups.
- Prepare written investment theses and stock pitches prior to implementing active recommendations.
- Succinctly summarize investment conclusions, including key risks and reasons to own.
- Assess the long-term viability of companies and defend investment opinions to portfolio managers and peers.
- Track individual performance against a customized benchmark.
- Maintain an on-site presence a minimum of three days per week to support collaboration and team integration.
- Prepare two-page board reports and concise written stock summaries using a professional business writing style.
SE#510791481
Skills
BankingFinance